Risk factors of cycle acceleration in acutely admitted patients with bipolar disorder

Acta Psychiatrica Scandinavica

Volumn 130, Issue 5, 2014, Pages 388-396

  Finseth, P I ^a,b   Morken, G ^a,b   Malt, U F ^c,d   Andreassen, O A ^c,e   Vaaler, A E ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bipolar disorder; Cycle acceleration; In patient; Risk factors

Indexed keywords

ANTIDEPRESSANT AGENT;

ACUTE DISEASE; ADULT; BIPOLAR DISORDER; COMORBIDITY; DISEASE COURSE; DRINKING BEHAVIOR; FEMALE; HOSPITALIZATION; HUMAN; MALE; NORWAY; ODDS RATIO; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; ADULT; ALCOHOL DRINKING; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; NORWAY; ODDS RATIO; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84908613216     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12308     Document Type: Article

References (47)

1. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H. Recurrence of bipolar disorders and major depression. A life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003;253:236-240.
2. Whiteford HA, Degenhardt L, Rehm J et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013;382:1575-1586.
3. Goldberg JF, Garno JL, Harrow M. Long-term remission and recovery in bipolar disorder: a review. Curr Psychiatry Rep 2005;7:456-461.
4. Haghighat R. Lifelong development of risk of recurrence in depressive disorders. J Affect Disord 1996;41:141-147.
5. Kraepelin E. Manic-depressive insanity and paranoia, 8th edn. Edinburgh: ES Livingstone, 1921.
6. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl 1985;317:1-34.
7. Kessing LV, Mortensen PB, Bolwig TG. Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J Affect Disord 1998;47:31-39.
8. Berk M, Ng F, Dodd S, Goldberg JF, Malhi GS. Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder. Psychiatry Clin Neurosci 2010;64:367-371.
9. Harel EV, Levkovitz Y. Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review. Isr J Psychiatry Relat Sci 2008;45:121-128.
10. Licht RW, Gijsman H, Nolen WA, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008;118:337-346.
11. Dunner DL, Patrick V, Fieve RR. Rapid cycling manic depressive patients. Compr Psychiatry 1977;18:561-566.
12. Baldessarini RJ, Salvatore P, Khalsa HM, Imaz-Etxeberria H, Gonzalez-Pinto A, Tohen M. Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J Affect Disord 2012;136:149-154.
13. McElroy SL, Altshuler LL, Suppes T et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158:420-426.
14. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011;35:804-817.
15. Post RM. The status of the sensitization/kindling hypothesis of bipolar disorder. Curr Psychos Ther Rep 2004;2:135-141.
16. Ghaemi SN, Boiman EE, Goodwin FK. Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder. Biol Psychiatry 1999;45:137-144.
17. Tondo L, Baldessarini RJ, Vazquez G, Lepri B, Visioli C. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatr Scand 2013;127:355-364.
18. Fava GA, Offidani E. The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1593-1602.
19. Yerevanian BI, Koek RJ, Mintz J, Akiskal HS. Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants. J Affect Disord 2007;103:13-21.
20. Wehr TA, Goodwin FK. Do antidepressants cause mania? Psychopharmacol Bull 1987;23:61-65.
21. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:1130-1138.
22. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004;161:163-165.
23. Joffe RT, Macqueen GM, Marriott M, Robb J, Begin H, Young LT. Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. Acta Psychiatr Scand 2002;105:427-430.
24. Goodwin FK, Jamison KR. Manic-depressive illness: bipolar disorders and recurrent depression, 2nd edn. New York: Oxford University Press, 2007.
25. Morken G, Vaaler AE, Folden GE, Andreassen OA, Malt UF. Age at onset of first episode and time to treatment in in-patients with bipolar disorder. Br J Psychiatry 2009;194:559-560.
26. Schoeyen HK, Birkenaes AB, Vaaler AE et al. Bipolar disorder patients have similar levels of education but lower socio-economic status than the general population. J Affect Disord 2011;129:68-74.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
28. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV - patient version. New York, NY: American Psychiatric Press, 1997.
29. Post RM, Nolen WA, Kupka RW et al. The Stanley Foundation Bipolar Network. I. Rationale and methods. Br J Psychiatry Suppl 2001;41:s169-s176.
30. Suppes T, Leverich GS, Keck PE et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001;67:45-59.
31. Finseth PI, Morken G, Andreassen OA, Malt UF, Vaaler AE. Risk factors related to lifetime suicide attempts in acutely admitted bipolar disorder inpatients. Bipolar Disord 2012;14:727-734.
32. Drancourt N, Etain B, Lajnef M et al. Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment. Acta Psychiatr Scand 2013;127:136-144.
33. Post RM, Luckenbaugh DA, Leverich GS et al. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry 2008;192:150-151.
34. Goldberg JF, Whiteside JE. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002;63:791-795.
35. Ghaemi SN. A clinician's guide to statistics and epidemiology in mental health: Measuring truth and uncertainty. New York, NY: Cambridge University Press, 2009.
36. Leverich GS, Post RM, Keck PE Jr et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr 2007;150:485-490.
37. Bauer M, Beaulieu S, Dunner DL, Lafer B, Kupka R. Rapid cycling bipolar disorder-diagnostic concepts. Bipolar Disord 2008;10:153-162.
38. Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken, NJ: John Wiley & Sons, 2013.
39. Suppes T, Dennehy EB, Gibbons EW. The longitudinal course of bipolar disorder. J Clin Psychiatry 2000;61:23-30.
40. Leibenluft E. Women and bipolar disorder: an update. Bull Menninger Clin 2000;64:5-17.
41. Marwaha S, Durrani A, Singh S. Employment outcomes in people with bipolar disorder: a systematic review. Acta Psychiatr Scand 2013;128:179-193.
42. Kilzieh N, Akiskal HS. Rapid-cycling bipolar disorder. An overview of research and clinical experience. Psychiatr Clin North Am 1999;22:585-607.
43. Strejilevich SA, Martino DJ, Marengo E et al. Long-term worsening of bipolar disorder related with frequency of antidepressant exposure. Ann Clin Psychiatry 2011;23:186-192.
44. Amsterdam JD, Shults J. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? J Affect Disord 2009;115:234-240.
45. Ghaemi SN, Ostacher MM, El-Mallakh RS et al. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 2010;71:372-380.
46. Post RM, Leverich GS, Altshuler LL et al. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. J Clin Psychiatry 2012;73:924-930.
47. Dodd S, Maes M, Anderson G, Dean OM, Moylan S, Berk M. Putative neuroprotective agents in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2013;42:135-145.